Abstract
The recent availability of new antiretroviral agents for the treatment of human immunodeficiency virus (HIV) infection has increased treatment options and has improved the durability, tolerability, and long-term efficacy of antiretroviral therapy, even among patients with extensive treatment experience and high levels of drug resistance. This expansion of therapeutic options has led to a revision of current treatment guidelines, which now state that the goal of antiretroviral therapy in all patients is suppression of the plasma HIV RNA level to
Original language | English (US) |
---|---|
Pages (from-to) | 214-221 |
Number of pages | 8 |
Journal | Clinical Infectious Diseases |
Volume | 48 |
Issue number | 2 |
DOIs | |
State | Published - Jan 15 2009 |
ASJC Scopus subject areas
- Infectious Diseases
- Microbiology (medical)
- General Medicine